RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY

被引：0
|
作者：
Katsumata, N. [1 ]
Fujiwara, Y. [1 ]
Katakami, N. [2 ]
Nishiwaki, Y. [3 ]
Tsuboi, M. [4 ]
Takeda, K. [5 ]
Nakanishi, T. [6 ]
Ichinose, Y. [7 ]
Kawahara, Y. [8 ]
Hotta, T. [6 ]
Saijo, N. [9 ]
机构：
[1] Natl Canc Ctr, Tokyo, Japan
[2] Inst Biomed Res & Innovat, Kobe, Hyogo, Japan
[3] Natl Canc Ctr Hosp E, Chiba, Japan
[4] Tokyo Med Univ Hosp, Tokyo, Japan
[5] Osaka City Gen Hosp, Osaka, Japan
[6] Nagoya Med Ctr, Natl Hosp Org, Aichi, Japan
[7] Kyushu Canc Ctr, Natl Hosp Org, Fukuoka, Japan
[8] Chuo Chest Med Ctr, Natl Hosp Org Kinki, Osaka, Japan
[9] Kinki Univ, Sch Med, Osaka 589, Japan
来源：
VOX SANGUINIS | 2009年 / 97卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [1] RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE III STUDY OF WEEKLY ADMINISTRATION OF DARBEPOETIN ALFA (DA) IN ANEMIC PATIENTS WITH LUNG OR GYNECOLOGIC CANCER RECEIVING PLATINUM-CONTAINING CHEMOTHERAPY
    Katakami, N.
    Nishiwaki, Y.
    Fujiwara, Y.
    Tsuboi, M.
    Takeda, K.
    Nakanishi, T.
    Ichinose, Y.
    Kawahara, M.
    Hotta, T.
    Saijo, N.
    ANNALS OF ONCOLOGY, 2008, 19 : 277 - 278
  • [2] Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy
    Vansteenkiste, J
    Pirker, R
    Massuti, B
    Barata, F
    Font, A
    Fiegl, M
    Siena, S
    Gateley, J
    Tomita, D
    Colowick, AB
    Musil, J
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (16) : 1211 - 1220
  • [3] Randomized Phase 2 Dose-finding Study of Weekly Administration of Darbepoetin Alfa in Anemic Patients with Lung or Ovarian Cancer Receiving Multicycle Platinum-containing Chemotherapy
    Ichinose, Yukito
    Seto, Takashi
    Nishiwaki, Yutaka
    Ohe, Yuichiro
    Yamada, Yoshiharu
    Takede, Koji
    Saijo, Nagahiro
    Hotta, Tomomitsu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (06) : 521 - 529
  • [4] Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy
    VanAudenrode, M
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (10) : 761 - 762
  • [5] Re: Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy - Response
    Vansteenkiste, JF
    Colowick, AB
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (10) : 762 - 763
  • [6] Randomized phaseii study of weekly administration of darbepoetin alfa (DA) in anemic patients with lung cancer and ovarian cancer receiving platinum-based chemotherapy
    Ohmatsu, Hironobu
    Nishiwaki, Yutaka
    Ichinose, Yukito
    Ohe, Yuichiro
    Yamada, Yoshiharu
    Takeda, Koji
    Saijo, Nagahiro
    Hotta, Tomomitsu
    ANNALS OF ONCOLOGY, 2006, 17 : 291 - 292
  • [7] Darbepoetin alfa for the treatment of anemia in patients with active cancer not receiving chemotherapy or radiotherapy: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled study
    Smith, Robert E.
    Aapro, Matti S.
    Ludwig, Heinz
    Pinter, Tamas
    Smakal, Martin
    Ciuleanu, Tudor E.
    Chen, Li
    Lillie, Tom
    Glaspy, John A.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (07) : 1040 - 1050
  • [8] Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy
    Witzig, TE
    Silberstein, PT
    Loprinzi, CL
    Sloan, JA
    Novotny, PJ
    Mailliard, JA
    Rowland, KM
    Alberts, SR
    Krook, JE
    Levitt, R
    Morton, RF
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2606 - 2617
  • [9] Results from a phase 3, randomized, double-blind, placebo-controlled study of darbepoetin alfa for the treatment of anemia in cancer patients not receiving chemotherapy or radiotherapy
    Glaspy, J. A.
    Smith, R. E.
    Aapro, M.
    Ludwig, H.
    Pinter, T.
    Smakal, M.
    Ciuleanu, T.
    Chen, L.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 136 - 136
  • [10] Quality of life, blood transfusions, and toxicity, in anemic patients with advanced cancer receiving weekly erythropoietin while on chemotherapy: Results from a phase III randomized double-blind placebo-controlled study.
    Sloan, JA
    Witzig, T
    Silberstein, P
    Novotny, PJ
    Allred, JB
    Baker, BA
    Loprinzi, CL
    BLOOD, 2002, 100 (11) : 287A - 287A
12345